# A Study of Patients With Fabry Disease (US Specific)

> **NCT06906367** · — · RECRUITING · sponsor: **Amicus Therapeutics** · enrollment: 450 (estimated)

## Conditions studied

- Fabry Disease

## Interventions

- **DRUG:** migalastat HCl
- **DRUG:** ERT

## Key facts

- **NCT ID:** NCT06906367
- **Lead sponsor:** Amicus Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-13
- **Primary completion:** 2032-06
- **Final completion:** 2032-06
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06906367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06906367, "A Study of Patients With Fabry Disease (US Specific)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06906367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*